EKF Diagnostics Holdings plc (EKF.L) (LON:EKF) shares gapped up prior to trading on Tuesday . The stock had previously closed at $72.00, but opened at $75.00. EKF Diagnostics Holdings plc (EKF.L) shares last traded at $73.15, with a volume of 1,179,209 shares traded.
The firm’s 50 day moving average is GBX 65.36 and its 200 day moving average is GBX 58.77. The company has a market cap of £340.11 million and a PE ratio of 52.14. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.74 and a quick ratio of 1.34.
About EKF Diagnostics Holdings plc (EKF.L) (LON:EKF)
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, and Africa. It offers DiaSpect and DiaSpect T hemoglobin analyzers; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a point-of-care hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
Featured Story: What Is Dividend Yield and How Do You Calculate It?
Receive News & Ratings for EKF Diagnostics Holdings plc (EKF.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics Holdings plc (EKF.L) and related companies with MarketBeat.com's FREE daily email newsletter.